Menu

Barinthus Biotherapeutics PLC BRNS

Full chart Compare
Set alert

Price alert · BRNS

All alert types
0.74 USD -0.02 (-2.49%)

At closeSep 8, 2026, 4:00 PM EDT

0.74 0.00 -0.57%

After hours · Sep 8, 4:00 PM ET

0.6421 Day range 0.7629
0.801 52-week range 4.16
YTD
+5.73%
1 year
-19.82%

Revenue & Expenses

Other Income → Expenses: $6.85MIncome Tax Benefit → Expenses: $44.00KExpenses → Selling, General & Admin: $29.67MExpenses → Research & Development: $38.25MExpenses → Other Operating Expenses: $15.02MGross Profit → Expenses: $14.97MRevenue → Gross Profit: $14.97MNet Loss → Expenses: $61.07MOther Income$6.85MIncome Tax Benefit$44.00KGross Profit$14.97MNet Loss$61.07MExpenses$82.94MSelling, General & Admin$29.67MResearch & Development$38.25MOther Operating Expenses$15.02MRevenue$14.97M

Latest period ending Dec 31, 2025 · select a line to chart its full history

BRNS annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-70.56M-67.97M-83.91M-4.04M-45.22M
-66.43M-61.07M-73.35M5.34M-50.87M
-1.64-1.55-1.910.14-1.96
BRNS annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
71.85M112.40M142.09M194.38M214.05M
98.17M160.33M214.51M270.20M280.71M
23.88M30.19M27.51M27.00M28.15M
11.28M12.01M12.98M8.77M7.22M
74.21M130.03M186.78M242.90M252.13M
BRNS annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-47.98M-28.94M-50.92M-14.43M-32.58M
416.00K-892.00K-5.41M-5.75M-12.91M
2.00K2.16M1.87M325.00K222.74M
416.00K-892.00K-5.41M-5.75M-1.15M
-40.55M-29.69M-52.30M-19.67M170.79M